Johnson & Johnson diabetes drug tops older therapies in studies

Posted by admin | Posted in weight loss | Posted on 10-06-2012-05-2008

0

The J&J drug, canagliflozin, also led to significantly greater weight loss than both of the other drugs and far fewer incidents of hypoglycemia, or potentially dangerous drops in blood sugar levels, than glimepiride, a member of the sulfonylurea class
See all stories on this topic ยป

Comments are closed.